期刊文献+

左西孟旦治疗急性心力衰竭60例临床分析 被引量:10

原文传递
导出
摘要 目的:观察左西孟旦治疗急性心力衰竭的临床疗效。方法选取急性心力衰竭患者120例,按数字表法随机分为治疗组60例和对照组60例。在常规治疗基础上,对照组加用米力农治疗,治疗组加用左西孟旦治疗。比较两组疗效及治疗前后左室射血分数( LVEF)和血清脑钠肽前体( pro-BNP)水平。结果治疗组总有效率为93%,高于对照组的75%(χ^2=5.437,P <0.05);治疗后治疗组 LVEF、pro-BNP 分别为(48.0±5.8)%、(1738±243)pg/mL,对照组分别为(41.0±6.3)%、(2869±430)pg/mL,两组差异均有统计学意义( t=2.754、2.425,均P<0.05)。结论左西孟旦对急性心力衰竭患者的疗效较好,能明显改善患者心脏收缩功能,且不良反应较少。
出处 《中国基层医药》 CAS 2014年第24期3803-3805,共3页 Chinese Journal of Primary Medicine and Pharmacy
  • 相关文献

参考文献15

二级参考文献191

  • 1汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 2谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 3赵雪燕,杨跃进,倪新海,党爱民,张健,黄洁,康晟,毛懿,马卫华,赵冬云.左心衰竭患者B型利钠肽与心功能指标的相关性分析[J].中国循环杂志,2006,21(3):168-171. 被引量:17
  • 4Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology, 2006, 104: 556-569.
  • 5Haikala H, Nissinen E, Etemadzadeh E, et al. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol, 1995, 25: 794-801.
  • 6Jonsson EN, Antila S, McFadyen L, et al. Population pharmaeokinetics of levosimcndan in patients with congestive heart failure. Br J Clin Pharmacol, 2003, 55: 544-551.
  • 7Antila S, Jarvinen A, Honkanen T, et al. Pharmacokinetic and pharmacodynamic interactions between the novel calcium sensitiser levosi- mendan and warfarin. Eur J Clin Pharmacol, 2000, 56: 705-710.
  • 8Kersten JR, Montgomery MW, Pagel PS, et al. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of KATP channels. Anesth Analg, 2000, 90: 5-11.
  • 9Bowman P, Haikala H, Paul RJ. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther, 1999, 288: 316-325.
  • 10Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study) :a randomised double-blind trial. Lancet, 2002, 360: 196-202.

共引文献984

同被引文献80

  • 1祝晓,刘伊娜,朱健华,吴翔.重组人脑利钠肽对急性心力衰竭患者心功能的影响[J].中国血液流变学杂志,2014(1):44-46. 被引量:6
  • 2唐宇.硝普钠与米力农对急性心力衰竭的治疗对比分析[J].现代养生,2014,0(8):80-80. 被引量:3
  • 3Kumarswamy R, Thun T. Non-coding RNAs in cardiac remodel- ing and heart failure. Circ Res, 2013,113 : 676-689.
  • 4Coons JC, McGraw M, Murali S. Pharmacotherapy for acute heart failure syndromes. Am J Health Syst Pharm, 2011,68 : 21 - 35.
  • 5Roqnoni A, Lupi A, Lazzero M, et al. Levosimendan: from ba- sic science to clinical trials. Recent Pat Cardiovasc Drug Discov, 2011,6:9-15.
  • 6鲍晓明,高希春.左西孟旦治疗急性失代偿性心力衰竭的临床疗效观察.健康必读(下旬刊),2013,3:42-43.
  • 7周海蓉,李治国.左西孟旦治疗老年重度心力衰竭的疗效及安全性观察.中国保健营养,2014,24:705-706.
  • 8Hurni C. Difficulties in diagnosis and treatment of heart failure. Ther Umsch, 2015,72 : 33-37.
  • 9Link A, Poss J, Bohm M. Pharmacotherapy of acute heart fail- ure : update and perspectives. Dtsch Med Wochenschr, 2012,137 : 126-129.
  • 10McCann P, Hauptman PJ. Inotropic therapy: an important role in the treatment of advanced symptomatic heart failure. Med Clim North Am, 2012,96: 943-954.

引证文献10

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部